Now showing items 1-2 of 2

  • Bevacizumab in the treatment of NSCLC: patient selection and perspectives 

    Russo, Alessia E; Priolo, Domenico; Antonelli, Giovanna; Libra, Massimo; McCubrey, James A; Ferraù, Francesco (2017-12-14)
    Non-small-cell lung cancer (NSCLC) represents about 85% of all lung cancers, and more than half of NSCLCs are diagnosed at an advanced stage. Chemotherapy has reached a plateau in the overall survival curve of about 10 ...
  • m6A’s Unique and Dynamic Role in Breast Cancer Progression 

    Dorgham, Mohammed Gamal (East Carolina University, 2023-07-18)
    Despite intense study, metastatic breast cancer is still the second leading cause of female death from cancer in the US. While many genetic lesions and environmental factors have been implicated in breast cancer progression, ...